<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2024-9.5.23</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-5052</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕДИАТРИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PEDIATRICS</subject></subj-group></article-categories><title-group><article-title>Особенности цитокинового статуса и нарушения гемостаза у детей с ювенильным идиопатическим артритом (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Cytokine status and hemostasis disorders in children with juvenile idiopathic arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0441-4548</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гомелля</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gomellya</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гомелля Марина Владимировна – доктор медицинских наук, профессор кафедры детских болезней и детских инфекций</p><p>664003, г. Иркутск, ул. Красного Восстания, 1</p></bio><bio xml:lang="en"><p>Marina V. Gomellya – Dr. Sc. (Med.), Professor at the Department of Children’s Diseases and Children’s Infections</p><p>Krasnogo Vosstaniya str. 1, Irkutsk 664003</p></bio><email xlink:type="simple">marina_gomellya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-7774-4836</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронова Анастасия Витальевна – ассистент кафедры детских болезней и детских инфекций</p><p>664003, г. Иркутск, ул. Красного Восстания, 1</p></bio><bio xml:lang="en"><p>Anastasia V. Mironova – Teaching Assistant at the Department of Children’s Diseases and Children’s Infections</p><p>Krasnogo Vosstaniya str. 1, Irkutsk 664003</p></bio><email xlink:type="simple">tav23_97_1997@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0285-3627</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крупская</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Krupskaya</surname><given-names>T. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крупская Тамара Семёновна – кандидат медицинских наук, заведующая кафедрой детских болезней и детских инфекций</p><p>664003, г. Иркутск, ул. Красного Восстания, 1</p></bio><bio xml:lang="en"><p>Tamara S. Krupskaya – Cand. Sc. (Med.), Head of the Department of Children’s Diseases and Children’s Infections</p><p>Krasnogo Vosstaniya str. 1, Irkutsk 664003</p></bio><email xlink:type="simple">krupskaya-tamara@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8212-9734</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Татаринова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tatarinova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татаринова Александра Валерьевна – ассистент кафедры детских болезней и детских инфекций</p><p>664003, г. Иркутск, ул. Красного Восстания, 1</p></bio><bio xml:lang="en"><p>Alexandra V. Tatarinova – Teaching Assistant at the Department of Children’s Diseases and Children’s Infections</p><p>Krasnogo Vosstaniya str. 1, Irkutsk 664003</p></bio><email xlink:type="simple">alexandra.tatarinova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Иркутский государственный медицинский университет» Минздрава России</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>23</day><month>11</month><year>2024</year></pub-date><volume>9</volume><issue>5</issue><fpage>211</fpage><lpage>220</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гомелля М.В., Миронова А.В., Крупская Т.С., Татаринова А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гомелля М.В., Миронова А.В., Крупская Т.С., Татаринова А.В.</copyright-holder><copyright-holder xml:lang="en">Gomellya M.V., Mironova A.V., Krupskaya T.S., Tatarinova A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/5052">https://www.actabiomedica.ru/jour/article/view/5052</self-uri><abstract><p>Ювенильный идиопатический артрит – хроническое воспалительное заболевание суставов у детей до 16 лет жизни, связанное с патологическим иммунным ответом на различные антигены. Вероятными факторами являются инфекционные и иммуногенетические. Процесс начинается с активации гуморального иммунитета. Одно из ключевых мест в патогенезе ювенильного идиопатического артрита занимает повреждение сосудистого эндотелия. Развивается иммунокомплексный васкулит с нарушениями системы гемостаза, микроциркуляторного русла в синовиальной оболочке. Вырабатываются провоспалительные цитокины, вызывающие разрушение синовиальной оболочки сустава, хряща, кости, способствующие хронизации воспалительного процесса. У пациентов с ревматическими заболеваниями изменения в системе гемостаза встречаются в 4,5–63 % случаев, особенно при высокой активности воспалительного процесса. При ювенильном идиопатическом артрите нарушения в системе гемостаза включают тромбинемию, снижение антитромбина III, увеличение количества D-димера, снижение активности фибринолиза. Использование теста тромбодинамики у взрослых с ревматоидным артритом показало наличие хронического гиперкоагуляционного состояния. Ревматоидный артрит является фактором риска тромботических осложнений у взрослых. Данные об исследовании параметров тромбодинамики при ювенильном идиопатическом артрите отсутствуют. В настоящее время известна патогенетическая общность между аутоиммунными заболеваниями, такими как системная красная волчанка, ревматоидный артрит и иммуноопосредованный антифосфолипидный синдром. Механизмы развития антифосфолипидного синдрома связаны с нарушением баланса системы гемостаза под влиянием аутоантител к фосфолипидам клеточных мембран, которые могут взаимодействовать с эндотелиальными клетками, различными компонентами свёртывающей системы, приводя к тромботическим осложнениям. Важность изучения иммуноопосредованного антифосфолипидного синдрома при ювенильном идиопатическом артрите не вызывает сомнения, однако данные по этому вопросу в детской популяции крайне ограничены, включая взаимосвязь антифосфолипидного синдрома с иммуно-гемостазиологическими параметрами. Единичные исследования иммуноопосредованного антифосфолипидного синдрома у детей с ювенильным идиопатическим артритом свидетельствуют о том, что маркеры антифосфолипидного синдрома выявляются при всех вариантах ювенильного идиопатического артрита, хотя тромботические осложнения встречаются редко.</p></abstract><trans-abstract xml:lang="en"><p>Juvenile idiopathic arthritis is a chronic inflammatory joint disease in children under 16 years of age associated with pathological immune response to various antigens. Probable factors are infectious and immunogenetic. The process begins with the activation of humoral immunity. One of the key components of juvenile idiopathic arthritis pathogenesis is damage to the vascular endothelium. Immune complex vasculitis develops with hemostasis and microcirculation disorders in synovial membrane. Proinflammatory cytokines are produced, causing the destruction of the synovial membrane of the joint, cartilage, bone, contributing to the chronicity of the inflammatory process. In patients with rheumatic diseases, hemostatic changes occur in 4.5–63 % of cases, especially with high activity of the inflammatory process. In juvenile idiopathic arthritis, hemostasis disorders include thrombinemia, decreased antithrombin III, increased D-dimer level, and decreased fibrinolysis activity. Thrombodynamics test in adults with rheumatoid arthritis has shown the presence of a chronic hypercoagulable state. Rheumatoid arthritis is a risk factor for thrombotic complications in adults. There are no data on the study of thrombodynamic parameters in juvenile idiopathic arthritis. Currently, the pathogenetic commonality between autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and immune-mediated antiphospholipid syndrome is known. The mechanisms of development of antiphospholipid syndrome are associated with an imbalance in the hemostasis system under the influence of autoantibodies to phospholipids of cell membranes, which can interact with endothelial cells, various components of the coagulation system, causing thrombotic complications. The importance of studying immune-mediated antiphospholipid syndrome in juvenile idiopathic arthritis is beyond doubt, but data on this issue in the pediatric population are extremely limited, including the relationship of antiphospholipid syndrome with immune hemostasis parameters. Single studies of immune-mediated antiphospholipid syndrome in children with juvenile idiopathic arthritis indicate that antiphospholipid syndrome markers are found in all variants of juvenile idiopathic arthritis, although thrombotic complications are rare.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ювенильный идиопатический артрит</kwd><kwd>дети</kwd><kwd>гемостаз</kwd><kwd>тромбодинамика</kwd><kwd>антифосфолипидный синдром</kwd></kwd-group><kwd-group xml:lang="en"><kwd>juvenile idiopathic arthritis</kwd><kwd>children</kwd><kwd>hemostasis</kwd><kwd>thrombodynamics</kwd><kwd>antiphospholipid syndrome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А., Намазова-Баранова Л.С., Алексеева Е.И., Валиева С.И., Бзарова Т.М., Никишина И.П. Юношеский артрит: клинические рекомендации. М.: Союз педиатров России»; 2017.</mixed-citation><mixed-citation xml:lang="en">Baranov AA, Namazova-Baranova LS, Alekseeva EI, Valieva SI, Bzarova TM, Nikishina IP. Juvenile arthritis: Clinical guidelines. Moscow: Union of Pediatricians of Russia; 2017. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Зорин И.В., Фроленко А.Л., Карымова Г.К., Месяц Д.С., Альшеева З.Т. Ювенильный идиопатический артрит: клинический случай. Лечащий врач. 2023; 7-8(26): 7-13.</mixed-citation><mixed-citation xml:lang="en">Zorin IV, Frolenko AL, Karymova GK, Mesyats DS, Alsheeva ZT. Juvenile idiopathic arthritis: Clinical case. Lechaschi vrach. 2023; 7-8(26): 7-13. (In Russ.). doi: 10.51793/OS.2023.26.8.001</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Савостьянов К.В., Алексеева Е.И., Чистяков Д.А. Ассоциация генов, не кодирующих компоненты главного комплекса гистосовместимости, с ювенильным идиопатическим артритом. Вестник РАМН. 2014; (9-10): 83-94.</mixed-citation><mixed-citation xml:lang="en">Savost’anov KV, Alexeeva EI, Chistiakov DA. Contribution of non-HLA genes to juvenile idiopathic arthritis susceptibility. Annals of the Russian Academy of Medical Sciences. 2014; (9-10): 83-94. (In Russ.). doi: 10.29296/25877305-2021-03-10</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е.Л. Проблемы иммунопатологии ревматоидного артрита: эволюция болезни. Научно-практическая ревматология. 2017; 55(3): 277-294.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL. Problems of rheumatoid arthritis immunopathology: Evolution of the disease. Rheumatology Science and Practice. 2017; 55(3): 277-294. (In Russ.). doi: 10.14412/1995-4484-2017-277-294</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Суховьёва О.Г., Жолобова Е.С., Николаева М.Н. Состояние плазменного звена гемостаза до и после пульс-терапии метилпреднизолоном при системной форме ювенильного ревматоидного артрита. Доктор.Ру. 2013; 3(81): 24-30.</mixed-citation><mixed-citation xml:lang="en">Sukhoviyova OG, Zholobova ES, Nikolaeva MN. Plasma hemostatic parameters before and after methylprednisolone pulse treatment in patients with systemic-onset juvenile rheumatoid arthritis. Doctor. Ru. 2013; 3(81): 24-30. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Avcin T, Ambrozic A, Kuhar M, Kveder T, Rozman B. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology (Oxford). 2001; 40(5): 565-573. doi: 10.1093/rheumatology/40.5.565</mixed-citation><mixed-citation xml:lang="en">Avcin T, Ambrozic A, Kuhar M, Kveder T, Rozman B. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology (Oxford). 2001; 40(5): 565-573. doi: 10.1093/rheumatology/40.5.565</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Маллаев Ш.Ш., Алимов А.В., Бобомуратов Т.А., Динмухаммадиева Д.Р. Клиническое течение ювенильного ревматоидного артрита и его оптимизация лечения. Педиатрия. 2020; 2: 200-203.</mixed-citation><mixed-citation xml:lang="en">Mallaev ShSh, Alimov AV, Bobomuratov TA, Dinmuhammadiyeva DR. Juvenile idiopathic arthritis in children: A modern view of the problem. Pediatrics. 2020; 2: 200-203. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile idiopathic arthritis. Balkan Med J. 2017; 34(2): 90-101. doi: 10.4274/balkanmedj.2017.0111</mixed-citation><mixed-citation xml:lang="en">Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile idiopathic arthritis. Balkan Med J. 2017; 34(2): 90-101. doi: 10.4274/balkanmedj.2017.0111</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Gong W, Liu L, Yan R, Wang S, Yuan Z. Integrative analysis of transcriptome-wide association study and gene-based association analysis identifies in silico candidate genes associated with juvenile idiopathic arthritis. Int J Mol Sci. 2022; 23(21): 13555. doi: 10.3390/ijms232113555</mixed-citation><mixed-citation xml:lang="en">Liu S, Gong W, Liu L, Yan R, Wang S, Yuan Z. Integrative analysis of transcriptome-wide association study and gene-based association analysis identifies in silico candidate genes associated with juvenile idiopathic arthritis. Int J Mol Sci. 2022; 23(21): 13555. doi: 10.3390/ijms232113555</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">La Bella S, Rinaldi M, Di Ludovico A, Di Donato G, Di Donato G, Salpietro V, et al. Genetic background and molecular mechanisms of juvenile idiopathic arthritis. Int J Mol Sci. 2023; 24(3): 1846. doi: 10.3390/ijms24031846</mixed-citation><mixed-citation xml:lang="en">La Bella S, Rinaldi M, Di Ludovico A, Di Donato G, Di Donato G, Salpietro V, et al. Genetic background and molecular mechanisms of juvenile idiopathic arthritis. Int J Mol Sci. 2023; 24(3): 1846. doi: 10.3390/ijms24031846</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer J, Dirks J, Haase G, Holl-Wieden A, Hofmann C, Girschick H, et al. IL-21+ CD4+ T helper cells co-expressing IFN-γ and TNF-α accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis. Clin Immunol. 2020; 217: 108484. doi: 10.1016/j.clim.2020.108484</mixed-citation><mixed-citation xml:lang="en">Fischer J, Dirks J, Haase G, Holl-Wieden A, Hofmann C, Girschick H, et al. IL-21+ CD4+ T helper cells co-expressing IFN-γ and TNF-α accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis. Clin Immunol. 2020; 217: 108484. doi: 10.1016/j.clim.2020.108484</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zaripova LN, Midgley A, Christmas SE, Beresford WA, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: From etitogenesis to treatment. Pediatrician Rheumatol Online J. 2021; 19: 135. doi: 10.1186/s12969-021-00629-8</mixed-citation><mixed-citation xml:lang="en">Zaripova LN, Midgley A, Christmas SE, Beresford WA, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: From etitogenesis to treatment. Pediatrician Rheumatol Online J. 2021; 19: 135. doi: 10.1186/s12969-021-00629-8</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Feng M, Kang M, He F, Xiao Z, Liu Z, Yao H et al. Plasma interleukin-37 increases and inhibits inflammatory cytokine production in peripheral blood mononuclear cells in patients with systemic juvenile idiopathic arthritis. J Transl Immunol. 2018; 16: 2771. doi: 10.1186/s12967-018-1655-8</mixed-citation><mixed-citation xml:lang="en">Feng M, Kang M, He F, Xiao Z, Liu Z, Yao H et al. Plasma interleukin-37 increases and inhibits inflammatory cytokine production in peripheral blood mononuclear cells in patients with systemic juvenile idiopathic arthritis. J Transl Immunol. 2018; 16: 2771. doi: 10.1186/s12967-018-1655-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Пашнина И.А., Криволапова И.М., Черешнева М.В. Концентрация IL-1β и TNFα в супернатантах культур клеток периферической крови у детей с аутоиммунной и инфекционной патологией. Российский иммунологический журнал. 2020; 23(3): 271-278.</mixed-citation><mixed-citation xml:lang="en">Pashnina IA, Krivolapova IM, Chereshneva MV. IL-1β and TNFα measured in supernatants of peripheral blood cell cultures from children with autoimmune and infectious pathology. Russian Journal of Immunology. 2020; 23(3): 271-278. (In Russ.). doi: 10.46235/1028-7221-336-IAT</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Akioka S. Interleukin-6 in juvenile idiopathic arthritis. Mod Rheumatol. 2019; 29: 275-286. doi: 10.1080/14397595.2019.1574697</mixed-citation><mixed-citation xml:lang="en">Akioka S. Interleukin-6 in juvenile idiopathic arthritis. Mod Rheumatol. 2019; 29: 275-286. doi: 10.1080/14397595.2019.1574697</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Peng Y, Liu X, Duan Z, Duan J, Zhou Y. The association of serum IL-10 levels with the disease activity in systemic-onset juvenile idiopathic arthritis patients. Mediat Inflamm. 2021; 2021: 1. doi: 10.1155/2021/6650928</mixed-citation><mixed-citation xml:lang="en">Peng Y, Liu X, Duan Z, Duan J, Zhou Y. The association of serum IL-10 levels with the disease activity in systemic-onset juvenile idiopathic arthritis patients. Mediat Inflamm. 2021; 2021: 1. doi: 10.1155/2021/6650928</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y, Wang Z, Chi H, Hu Q, Ye J, Liu H et al. Elevated serum levels of interleukin-10 in adult-onset Still’s disease are associated with disease activity. Clin Rheumatol. 2019; 38: 3205-3210. doi: 10.1007/s10067-019-04642</mixed-citation><mixed-citation xml:lang="en">Sun Y, Wang Z, Chi H, Hu Q, Ye J, Liu H et al. Elevated serum levels of interleukin-10 in adult-onset Still’s disease are associated with disease activity. Clin Rheumatol. 2019; 38: 3205-3210. doi: 10.1007/s10067-019-04642</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Кетлинский С.А., Симбирцев А.С. Цитокины. СПб.: Фолиант; 2008. [Ketlinsky SA, Simbirtsev AS. Cytokines. Saint Petersburg: Foliant; 2008. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Кетлинский С.А., Симбирцев А.С. Цитокины. СПб.: Фолиант; 2008. [Ketlinsky SA, Simbirtsev AS. Cytokines. Saint Petersburg: Foliant; 2008. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021; 22: 2719. doi: 10.3390/ijms22052719</mixed-citation><mixed-citation xml:lang="en">Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021; 22: 2719. doi: 10.3390/ijms22052719</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Dong C, Fu T, Ji J, Li Z, Gu Z. The role of interleukin-4 in rheumatic diseases. Clin Exp Pharmacol Physiol. 2018; 45(8): 747-754. doi: 10.1111/1440-1681.12946</mixed-citation><mixed-citation xml:lang="en">Dong C, Fu T, Ji J, Li Z, Gu Z. The role of interleukin-4 in rheumatic diseases. Clin Exp Pharmacol Physiol. 2018; 45(8): 747-754. doi: 10.1111/1440-1681.12946</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Спиваковская А.Ю., Спиваковский Ю.М., Черненков Ю.В. Анализ клинико-иммунологических показателей у детей с суставной патологией. Российский вестник перинатологии и педиатрии. 2018; 63(6): 55-59.</mixed-citation><mixed-citation xml:lang="en">Spivakovskaya AYu, Spivakvskiy YuM, Chernenkov YuV. Analysis of clinical and immunological parameters in children with joint pathology. Russian Bulletin of Perinatology and Pediatrics. 2018; 63(6): 55-59. (In Russ.). doi: 10.21508/1027-4065-2018-63-5-55-59</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP. [Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi. 2019; 40(1): 52-57. (In Chinese). doi: 10.3760/cma.j.issn.0253-2727.2019.01.010</mixed-citation><mixed-citation xml:lang="en">Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP.  [Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi. 2019; 40(1): 52-57. (In Chinese). doi: 10.3760/cma.j.issn.0253-2727.2019.01.010</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Karimdzhanov IA, Madaminova MSh, Umarov DA. The role of interleukin 17 in juvenile idiopathic arthritis. Child’s Health. 2024; 19(3): 134-139. doi: 10.22141/2224-0551.19.3.2024.1691</mixed-citation><mixed-citation xml:lang="en">Karimdzhanov IA, Madaminova MSh, Umarov DA. The role of interleukin 17 in juvenile idiopathic arthritis. Child’s Health. 2024; 19(3): 134-139. doi: 10.22141/2224-0551.19.3.2024.1691</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Marzetti V, Breda L, Miulli E, Filippetti F, Mancini C, Chiarelli F, et al. Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: A population-based study. Ann Ig. 2017; 29(4): 281-292. doi: 10.7416/ai.2017.2152</mixed-citation><mixed-citation xml:lang="en">Marzetti V, Breda L, Miulli E, Filippetti F, Mancini C, Chiarelli F, et al. Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: A population-based study. Ann Ig. 2017; 29(4): 281-292. doi: 10.7416/ai.2017.2152</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Журавлева Ю.А., Гусев Е.Ю. Взаимосвязь системной воспалительной реакции и гиперкоагуляции у пациентов с иммуновоспалительными ревматическими заболеваниями. Медицинская иммунология. 2023; 25(5): 1059-1064.</mixed-citation><mixed-citation xml:lang="en">Zhuravleva YuA, Gusev EYu. Relationship between systemic inflammatory response and hypercoagulation in patients with immuno-inflammatory rheumatic diseases. Medical Immunology (Russia). 2023; 25(5): 1059-1064. (In Russ.). doi: 10.15789/1563-0625-RBS-2817</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Musayeva N, Islamova Z. PB2633: Hemostasiological changes in rheumatoid arthritis. HemaSphere. 2023; 7(S3): e4555018. doi: 10.1097/01.HS9.0000977220.45550.18</mixed-citation><mixed-citation xml:lang="en">Musayeva N, Islamova Z. PB2633: Hemostasiological changes in rheumatoid arthritis. HemaSphere. 2023; 7(S3): e4555018. doi: 10.1097/01.HS9.0000977220.45550.18</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Чельдиева Ф.А., Решетняк Т.М. Ревматоидный артрит: некоторые компоненты гемостаза и воспаление. Современная ревматология. 2019; 13(3): 87-94.</mixed-citation><mixed-citation xml:lang="en">Cheldieva FA, Reshetnyak TM. Rheumatoid arthritis: Some components of hemostasis and inflammation. Modern Rheumatology Journal. 2019; 13(3): 87-94. (In Russ.). doi: 10.14412/1996-7012-2019-3-87-94</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е.Л., Авдеева А.С., Дибров Д.А. Ревматоидный артрит как клинико-иммунологический синдром: фокус на серонегативный субтип заболевания. Научно-практическая ревматология. 2023; 61(3): 276-291.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL, Avdeeva AS, Dibrov DA. Rheumatoid arthritis as a clinical and immunological syndrome: Focus on the seronegative subtype of the disease. Rheumatology Science and Practice. 2023; 61(3): 276-291. (In Russ.). doi: 10.47360/1995-4484-2023-276-291</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Klein A, Molad Y. Hematological manifestations among patients with rheumatic diseases. Acta Haematol. 2021; 144(4): 403-412. doi: 10.1159/000511759</mixed-citation><mixed-citation xml:lang="en">Klein A, Molad Y. Hematological manifestations among patients with rheumatic diseases. Acta Haematol. 2021; 144(4): 403-412. doi: 10.1159/000511759</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Скударнов Е.В., Лобанов Ю.Ф., Ковалев В.В., Григоревская О.А. Состояние гемостаза при ювенильном ревматоидном артрите у детей. Педиатрия. Журнал им. Г.Н. Сперанского. 2011; 90(5): 35-19.</mixed-citation><mixed-citation xml:lang="en">Lobanov YuF, Skudarnov EV, Kovalev VV, Grigorevskaya OA. Hemostasis in juvenile rheumatoid arthritis in children. Pediatria n. a. G.N. Speransky. 2011; 90(5): 35-19. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Богмат Л.В., Никонова В.В., Шевченко Н.С., Бессонова И.М. Особенности свертывающей системы у детей с ювенильным идиопатическим артритом. Здоровье ребенка. 2021; 16(2): 105-110.</mixed-citation><mixed-citation xml:lang="en">Bogmat LV, Nikonova VV, Shevchenko NS, Bessonova IM. Features of coagulation system in children with juvenile idiopathic arthritis. Child’s Health. 2021; 16(2): 105-110. (In Russ.). doi: 10.22141/2224-0551.16.2.2021.229873</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Черненков Ю.В., Захарова Н.Б., Кузьмина А.А., Спиваковский Ю.М. Современные методы ранней диагностики ювенильных артритов (обзор). Саратовский научно-медицинский журнал. 2013; 9(2): 308-313.</mixed-citation><mixed-citation xml:lang="en">Chernenkov YV, Zakharovа NB, Kuzminа АА, Spivakovsky YM. Modern methods of early diagnostics of juvenile arthritis (review). Saratov Journal of Medical Scientific Research. 2013; 9(2): 308-313. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Стрельникова Е.А., Трушкина П.Ю., Суров И.Ю., Короткова Н.В., Мжаванадзе Н.Д., Деев Р.В. Эндотелий in vivo и in vitro. Часть 1: гистогенез, структура, цитофизиология и ключевые маркеры. Наука молодых (Eruditio Juvenium). 2019; 7(3): 450-465.</mixed-citation><mixed-citation xml:lang="en">Strelnikova EA, Trushkina PYu, Surov IYu, Korotkova NV, Mzhavanadze ND, Deev RV. Endothelium in vivo and in vitro. Part 1: Histogenesis, structure, cytophysiology and key markers. Eruditio Juvenium. 2019; 7(3): 450-465. (In Russ.). doi: 10.23888/HMJ201973450-465</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Гомелля М.В. Геморрагический синдром у детей: учебное пособие. Иркутск: Иркутский государственный медицинский университет; 2021.</mixed-citation><mixed-citation xml:lang="en">Gomellya MV. Hemorrhagic syndrome in children: Textbook. Irkutsk: Irkutsk State Medical University; 2021. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Дивакова Ю.В., Колосков А.В. Эндотелиально-тромбоцитарное взаимодействие при сепсисе. Гематология и трансфузиология. 2022; 67(3): 406-418.</mixed-citation><mixed-citation xml:lang="en">Divakova YuV, Koloskov AV. Endothelial-platelet interaction in sepsis. Russian Journal of Hematology and Transfusiology. 2022; 67(3): 406-418. (In Russ.). doi: 10.35754/0234-5730-2022-67-3-406-418</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cafaro G, McInnes IB. Psoriatic arthritis: Tissue-directed inflammation? Clin Rheumatol 2018; 37(4): 859-868. doi: 10.1007/s10067-018-4012-7</mixed-citation><mixed-citation xml:lang="en">Cafaro G, McInnes IB. Psoriatic arthritis: Tissue-directed inflammation? Clin Rheumatol 2018; 37(4): 859-868. doi: 10.1007/s10067-018-4012-7</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Герасимова О.Н., Иванова О.В. Изменения в системе гемостаза и особенности межклеточных взаимодействий у детей с ювенильным ревматоидным артритом. Вестник новых медицинских технологий. 2010; 3: 99.</mixed-citation><mixed-citation xml:lang="en">Gerasimova ON, Ivanova OV. Changes in the hemostasis system and features of intercellular interactions in children with juvenile rheumatoid arthritis. Journal of New Medical Technologies. 2010; 3: 99. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zhigulina KV, Spitsina SS. Assessment of the main indicators of the hemostasis system in patients with rheumatoid arthritis. Virtual Congress. 2021; 1: 392.</mixed-citation><mixed-citation xml:lang="en">Zhigulina KV, Spitsina SS. Assessment of the main indicators of the hemostasis system in patients with rheumatoid arthritis. Virtual Congress. 2021; 1: 392.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Minaev AV, Gushchin DK, Kovalev DV, Mwela BM. Hemostasis assessment in Fontan patients using the new thrombodynamics test. Egypt Heart J. 2023; 75(1): 39. doi: 10.1186/s43044-023-00365-2</mixed-citation><mixed-citation xml:lang="en">Minaev AV, Gushchin DK, Kovalev DV, Mwela BM. Hemostasis assessment in Fontan patients using the new thrombodynamics test. Egypt Heart J. 2023; 75(1): 39. doi: 10.1186/s43044-023-00365-2</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Баландина А.Н., Кольцова Е.М., Шибеко А.М., Купраш А.Д., Атауллаханов Ф.И. Тромбодинамика: новый подход к диагностике нарушений системы гемостаза. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2018; 17(4): 114-126.</mixed-citation><mixed-citation xml:lang="en">Balandina AN, Koltsova EM, Shibeko AM, Kuprash AD, Ataullakhanov FI. Thrombodynamics: A new method to the diagnosis of hemostasis system disorders. Pediatric Hematology/Oncology and Immunopathology. 2018; 17(4): 114-126. (In Russ.). doi: 10.24287/1726-1708-2018-17-4-114-126</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Пешкова А.Д., Евдокимова Т.А., Сибгатуллин Т.Б., Атауллаханов Ф.И., Литвинов Р.И. Изменения параметров тромбодинамики и контракции сгустков крови у пациентов с ревматоидным артритом. Научно-практическая ревматология. 2020; 58(3): 294-303.</mixed-citation><mixed-citation xml:lang="en">Peshkova AD, Evdokimova TA, Sibgatullin TB, Ataullakhanov FI, Litvinov RI. Changes in the parameters of thrombodynamics and blood clot contraction in patients with rheumatoid arthritis. Rheumatology Science and Practice. 2020; 58(3): 294-303. (In Russ.). doi: 10.14412/1995-4484-2020-294-303</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Середавкина Н.В., Чельдиева Ф.А., Лила А.М., Решетняк Т.М. Протромботическое состояние при ревматоидном артрите. Здравоохранение Таджикистана. 2022; (4): 82-91.</mixed-citation><mixed-citation xml:lang="en">Seredavkina NV, Cheldieva FA, Lila AM, Reshetnyak TM. Prothrombotic state in rheumatoid arthritis. Health Care of Tajikistan. 2022; (4): 82-91. (In Russ.). doi: 10.52888/0514-2515-2022-355-4-82-91</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Стуров В.Г., Гуляева Л.Ф., Тамкович С.Н., Макарова С.И. Антифосфолипидный синдром: клинико-биохимические аспек-ты патогенеза, диагностики и лечения: учебно-методическое пособие. Новосибирск: Новосибирский государственный университет; 2024.</mixed-citation><mixed-citation xml:lang="en">Sturov VG, Gulyaeva LF, Tamkovich SN, Makarova SI. Antiphospholipid syndrome: Clinical and biochemical aspects of pathogenesis, diagnosis and treatment: Study guide. Novosibirsk: Novosibirsk State University; 2024. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: Analysis of 58 patients. Clin Rheumatol. 2018; 37: 1295-1303. doi: 10.1007/s10067-017-3776-5</mixed-citation><mixed-citation xml:lang="en">Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: Analysis of 58 patients. Clin Rheumatol. 2018; 37: 1295-1303. doi: 10.1007/s10067-017-3776-5</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Madison JA, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome. Eur J Rheumatol. 2019; 7: 1-10. doi: 10.5152/eurjrheum.2019.19160</mixed-citation><mixed-citation xml:lang="en">Madison JA, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome. Eur J Rheumatol. 2019; 7: 1-10. doi: 10.5152/eurjrheum.2019.19160</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Момот А.П., Тараненко И.А., Белозеров Д.Е., Цывкина Л.П., Фадеева Н.И., Медведева М.В. Инициация свертывания крови в разные сроки физиологически протекающей беременности. Сибирский медицинский журнал. 2014; 34(5): 58-66.</mixed-citation><mixed-citation xml:lang="en">Momot AP, Taranenko IA, Belozerov DE, Tsyvkina LP, Fadeeva NI, Medvedeva MV. Initiation of blood clotting in different stages of normal pregnancy. Siberian Medical Journal. 2014; 34(5): 58-66. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Rosina S, Chighizola CB, Ravelli A, Cimaz R. Pediatric antiphospholipid syndrome: From pathogenesis to clinical management. Curr Rheumatol Rep. 2021; 23(2): 10. doi: 10.1007/s11926-020-00976-7</mixed-citation><mixed-citation xml:lang="en">Rosina S, Chighizola CB, Ravelli A, Cimaz R. Pediatric antiphospholipid syndrome: From pathogenesis to clinical management. Curr Rheumatol Rep. 2021; 23(2): 10. doi: 10.1007/s11926-020-00976-7</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Islabão AG, Trindade VC, da Mota LMH, Andrade DCO, Silva CA. Managing antiphospholipid syndrome in children and adolescents: Current and future prospects. Paediatr Drugs. 2022; 24(1): 13-27. doi: 10.1007/s40272-021-00484-w</mixed-citation><mixed-citation xml:lang="en">Islabão AG, Trindade VC, da Mota LMH, Andrade DCO, Silva CA. Managing antiphospholipid syndrome in children and adolescents: Current and future prospects. Paediatr Drugs. 2022; 24(1): 13-27. doi: 10.1007/s40272-021-00484-w</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Meroni PL, Argolini LM, Pontikaki I. What is known about pediatric antiphospholipid syndrome? Expert Rev Hematol. 2016; 9: 977-985. doi: 10.1080/17474086.2016.1235969</mixed-citation><mixed-citation xml:lang="en">Meroni PL, Argolini LM, Pontikaki I. What is known about pediatric antiphospholipid syndrome? Expert Rev Hematol. 2016; 9: 977-985. doi: 10.1080/17474086.2016.1235969</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Острякова Е.В., Патрушев Л.И., Решетняк Т.М. Антифосфолипидный синдром и система фибринолиза. Научно-практическая ревматология. 2011; 49(6): 57-64.</mixed-citation><mixed-citation xml:lang="en">Ostryakova EV, Patrushev LI, Reshetnyak TM. The antiphospholipid syndrome and the fibrinolytic system. Rheumatology Science and Practice. 2011; 49(6): 57-64. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Groot N, Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, et al. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: The SHARE initiative. Ann Rheum Dis. 2017; 76(10): 1637-1641. doi: 10.1136/annrheumdis-2016-211001</mixed-citation><mixed-citation xml:lang="en">Groot N, Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, et al. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: The SHARE initiative. Ann Rheum Dis. 2017; 76(10): 1637-1641. doi: 10.1136/annrheumdis-2016-211001</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Шабалов Н.П. Детские болезни: учебник для вузов; 9-е изд., перераб. и доп. СПб.: Питер; 2021; 2.</mixed-citation><mixed-citation xml:lang="en">Shabalov NP. Pediatric diseases: Textbook for universities; 9th ed., revised and enlarged. Saint Petersburg: Piter; 2021; 2. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Soybilgic A, Avcin T. Pediatric APS: State of the art. Curr Rheumatol Rep. 2020; 22(3): 9. doi: 10.1007/s11926-020-0887-9</mixed-citation><mixed-citation xml:lang="en">Soybilgic A, Avcin T. Pediatric APS: State of the art. Curr Rheumatol Rep. 2020; 22(3): 9. doi: 10.1007/s11926-020-0887-9</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammed MJ, Hashim HT, Al-Obaidi AD, Al Shammari A. A novel overlap syndrome: Rheumatoid arthritis, Sjogren’s syndrome, antiphospholipid syndrome, and dermatomyositis. Clin Case Rep. 2023; 11(4): e7274. doi: 10.1002/ccr3.7274</mixed-citation><mixed-citation xml:lang="en">Mohammed MJ, Hashim HT, Al-Obaidi AD, Al Shammari A. A novel overlap syndrome: Rheumatoid arthritis, Sjogren’s syndrome, antiphospholipid syndrome, and dermatomyositis. Clin Case Rep. 2023; 11(4): e7274. doi: 10.1002/ccr3.7274</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023; 75(10): 1687-1702. doi: 10.1002/art.42624</mixed-citation><mixed-citation xml:lang="en">Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023; 75(10): 1687-1702. doi: 10.1002/art.42624</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Devreese KMJ, Groot PG, Laat B, Erkan D, Favaloro EJ, Mackie I, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020; 18(11): 2828-2839. doi: 10.1111/jth.15047</mixed-citation><mixed-citation xml:lang="en">Devreese KMJ, Groot PG, Laat B, Erkan D, Favaloro EJ, Mackie I, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020; 18(11): 2828-2839. doi: 10.1111/jth.15047</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">O’Leary RE, Hsiao JL, Worswick SD. Antiphospholipid syndrome in a patient with rheumatoid arthritis. Cutis. 2017; 99(3): 21-24.</mixed-citation><mixed-citation xml:lang="en">O’Leary RE, Hsiao JL, Worswick SD. Antiphospholipid syndrome in a patient with rheumatoid arthritis. Cutis. 2017; 99(3): 21-24.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Arabidze GG, Shapchenko AV, Muslimova OV, Larina OY, Sorokoletov AM. Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome. CardioSomatics. 2015; 6(3): 70-78. doi: 10.26442/CS45162</mixed-citation><mixed-citation xml:lang="en">Arabidze GG, Shapchenko AV, Muslimova OV, Larina OY, Sorokoletov AM. Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome. CardioSomatics. 2015; 6(3): 70-78. doi: 10.26442/CS45162</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
